Webinar : The Challenges of Resistance to Immunotherapy & Predicting Treatment Response | Replay available

Relive the webinar on “𝙏𝙝𝙚 𝘾𝙝𝙖𝙡𝙡𝙚𝙣𝙜𝙚𝙨 𝙤𝙛 𝙍𝙚𝙨𝙞𝙨𝙩𝙖𝙣𝙘𝙚 𝙩𝙤 𝙄𝙢𝙢𝙪𝙣𝙤𝙩𝙝𝙚𝙧𝙖𝙥𝙮 𝙖𝙣𝙙 𝙋𝙧𝙚𝙙𝙞𝙘𝙩𝙞𝙣𝙜 𝙏𝙧𝙚𝙖𝙩𝙢𝙚𝙣𝙩 𝙍𝙚𝙨𝙥𝙤𝙣𝙨𝙚,” that brought together two leading clinicians and two PSCC-supported startups developing innovative approaches to better predict treatment response.

🎤 With:

• Michel Ducreux, Professor of Oncology at Paris-Saclay University and Head of Gastrointestinal Oncology at Gustave Roussy.

 • François-Xavier Danlos, Medical Oncologist and Researcher at Gustave Roussy, specializing in immunotherapy and precision medicine.

• Arnaud Cutivet, co-founder & CEO of MSInsight, which develops solutions combining genomics and AI to improve the detection and interpretation of tumor and genetic biomarkers.

 • Etienne Formstecher, co-founder & CEO of GMT Science, which develops diagnostic tests combining gut microbiome analysis and AI.

See the replay :

https://vimeo.com/1240197540?share=copy&fl=sv&fe=ci